These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2178941)

  • 1. The effect of parenteral estrogen versus orchiectomy on blood coagulation and fibrinolysis in prostatic cancer patients.
    Aro J; Haapiainen R; Rasi V; Rannikko S; Alfthan O
    Eur Urol; 1990; 17(2):161-5. PubMed ID: 2178941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of orchiectomy and polyestradiol phosphate therapy on serum lipoprotein lipids and glucose tolerance in prostatic cancer patients.
    Aro J; Haapiainen R; Sane T; Rannikko S; Pelkonen R; Alfthan O
    Eur Urol; 1990; 17(3):229-35. PubMed ID: 2351192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in blood coagulation and fibrinolysis in patients on different treatment regimens for prostatic cancer. Predictors for cardiovascular complications?
    Blombäck M; Hedlund PO; Säwe U
    Thromb Res; 1988 Jan; 49(1):111-21. PubMed ID: 3126558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of parenteral polyestradiol phosphate in the treatment of advanced prostatic cancer on the threshold of the new millennium.
    Mikkola A; Ruutu M; Aro J; Rannikko S; Salo J
    Ann Chir Gynaecol; 1999; 88(1):18-21. PubMed ID: 10230677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orchiectomy, estrogen therapy and radiotherapy in locally advanced (T3-4 M0) prostatic cancer.
    Aro J; Haapiainen R; Kajanti M; Rannikko S; Alfthan O
    Scand J Urol Nephrol Suppl; 1988; 110():103-7. PubMed ID: 3187397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of primary orchiectomy and polyoestradiol phosphate in the treatment of advanced prostatic cancer. Finnprostate Group.
    Haapiainen R; Rannikko S; Alfthan O
    Br J Urol; 1990 Jul; 66(1):94-7. PubMed ID: 2132303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma androgen levels after subcapsular orchiectomy or estrogen treatment for prostatic carcinoma.
    Vermeulen A; Schelfhout W; De Sy W
    Prostate; 1982; 3(2):115-21. PubMed ID: 6211662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose polyoestradiol phosphate with and without acetosalicylic acid versus orchiectomy in the treatment of prostatic cancer. Finnprostate Group.
    Aro JL; Haapiainen RK; Rannikko SA; Alfthan OS
    Br J Urol; 1989 May; 63(5):512-4. PubMed ID: 2659136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of parenteral oestrogen on the coagulation system in patients with prostatic carcinoma.
    Henriksson P; Blombäck M; Eriksson A; Stege R; Carlström K
    Br J Urol; 1990 Mar; 65(3):282-5. PubMed ID: 2110842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular and all-cause mortality in prostatic cancer patients treated with estrogens or orchiectomy as compared to the standard population.
    Aro J
    Prostate; 1991; 18(2):131-7. PubMed ID: 2006119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ethinyl oestradiol/polyoestradiol phosphate and estramustine phosphate on some proteins related to haemostasis in prostatic carcinoma patients.
    Damber JE; Daehlin L; Tomic R; Nilsson TK
    Int Urol Nephrol; 1991; 23(3):251-6. PubMed ID: 1889971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible bone-preserving capacity of high-dose intramuscular depot estrogen as compared to orchidectomy in the treatment of patients with prostatic carcinoma.
    Carlström K; Stege R; Henriksson P; Grande M; Gunnarsson PO; Pousette A
    Prostate; 1997 May; 31(3):193-7. PubMed ID: 9167772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activators and inhibitors of coagulation and fibrinolysis in patients with prostatic cancer treated with oestrogen or orchidectomy.
    Henriksson P; Blombäck M; Bratt G; Edhag O; Eriksson A
    Thromb Res; 1986 Dec; 44(6):783-91. PubMed ID: 3798420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal regulation of serum lipoprotein (a) levels: effects of parenteral administration of estrogen or testosterone in males.
    Berglund L; Carlström K; Stege R; Gottlieb C; Eriksson M; Angelin B; Henriksson P
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2633-7. PubMed ID: 8675589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of endocrine and radiation therapy in locally advanced prostatic cancer.
    Aro J; Haapiainen R; Kajanti M; Rannikko S; Alfthan O
    Eur Urol; 1988; 15(3-4):182-6. PubMed ID: 3063541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parenteral estrogen versus total androgen ablation in the treatment of advanced prostate carcinoma: effects on overall survival and cardiovascular mortality. The Scandinavian Prostatic Cancer Group (SPCG)-5 Trial Study.
    Hedlund PO; Henriksson P
    Urology; 2000 Mar; 55(3):328-33. PubMed ID: 10699602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of cardiovascular complications in patients with prostatic cancer treated with estrogen.
    Henriksson P; Johansson SE
    Am J Epidemiol; 1987 Jun; 125(6):970-8. PubMed ID: 3578255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thyroid hormones in metastasizing prostate cancer treated with polyestradiol phosphate].
    Dunzendorfer U; Schulz H
    Z Urol Nephrol; 1982 Jul; 75(7):493-500. PubMed ID: 6183845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of hot flashes during treatment with parenteral estrogen or complete androgen ablation for metastatic carcinoma of the prostate.
    Spetz AC; Hammar M; Lindberg B; Spångberg A; Varenhorst E;
    J Urol; 2001 Aug; 166(2):517-20. PubMed ID: 11458057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary orchiectomy versus estrogen therapy in advanced prostatic cancer--a randomized study: results after 7 to 10 years of followup.
    Johansson JE; Andersson SO; Holmberg L; Bergström R
    J Urol; 1991 Mar; 145(3):519-22; discussion 522-3. PubMed ID: 1997702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.